European Medicines Group appoints new chair
The European Medicines Group (EMG) has elected Alexander Moscho, UK managing director of Bayer UK, as its new chair. He steps into the role vacated by Merck-Serono’s David Garmon-Jones. Alex will be supported in this role by Zinta Krumins, managing director of Boehringer Ingelheim who has been re-elected as vice-chair for the group and Mike Sumpter, managing director of Servier, who remains treasurer.
EMG represents UK operations of 18 research-driven pharmaceutical companies headquartered in continental Europe and which includes some of the biggest pharma houses in the UK industry.
Speaking following his appointment Alexander Moscho says: “It is a privilege to be elected as Chair and take up the role from David who has steered the European Medicines Group through the opportunities and challenges of the previous year. EMG will work with our stakeholders to ensure we play our part in creating a sustainable future for patients in the UK and for our industry.
“With the growing focus on the European Union and the future shape of the UK’s relationship with Europe generally, EMG’s views on the UK pharmaceutical industry’s place within this becomes even more relevant.”